Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease.
about
Autosomal dominant polycystic kidney disease: the last 3 yearsSoy-based renoprotectionIdentification of novel mutations in Chinese Hans with autosomal dominant polycystic kidney diseaseMolecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing.Determinants of renal disease variability in ADPKD.Detecting PKD1 variants in polycystic kidney disease patients by single-molecule long-read sequencing.High Resolution Melt analysis for mutation screening in PKD1 and PKD2.Molecular diagnostics for autosomal dominant polycystic kidney diseaseProtein phosphatase-1α interacts with and dephosphorylates polycystin-1Hyperphosphorylation of polycystin-2 at a critical residue in disease reveals an essential role for polycystin-1-regulated dephosphorylation.Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney diseaseNovel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease.Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney diseaseA novel long-range PCR sequencing method for genetic analysis of the entire PKD1 gene.Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney diseaseComprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.Type of PKD1 mutation influences renal outcome in ADPKD.The polycystin complex mediates Wnt/Ca(2+) signalling.System analysis of gene mutations and clinical phenotype in Chinese patients with autosomal-dominant polycystic kidney disease.Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiationAberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease.DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer families.Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.Autosomal dominant polycystic kidney disease caused by somatic and germline mosaicism.High-resolution melt as a screening method in autosomal dominant polycystic kidney disease (ADPKD).Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.Cisterna chyli in autosomal dominant polycystic kidney diseaseNovel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction
P2860
Q24656249-F44FA2AB-BEAB-443C-81A0-C46BB97DFF8DQ26751544-9C1842DD-56CC-42E7-AB60-B1B703C8F2F9Q30410875-53711864-2B24-419A-8371-80B9FD502781Q30417775-21219796-8B78-4E67-9F81-E52988DFEE80Q33723857-C187925A-D5FE-438B-9D24-F35D12B3FF85Q33845711-C4DAFADF-CDE1-4375-86BD-25BEBA7F4967Q34050928-B95847C7-D1A2-4B67-8AEA-E5DF4AAE7244Q34100184-ADF7E284-242B-405F-BA72-9004D3E4FEC5Q34295538-C0702C0D-8383-420F-8016-1691AD715EFBQ34326684-8B1E9400-9B6A-4EBB-BDE3-58D5081DEF70Q35125247-3DC9ABB7-44C9-484C-90F1-2010F0E0707CQ35138042-523A21BC-F458-4399-BCA8-1A9AC7E45179Q35505201-9B98DB78-8F35-4964-B14E-7626ED5AEDD4Q36081160-FA59051F-114F-423A-B894-3C9ACDF46B6BQ36343363-DD51EBD3-A4CB-4A95-893E-C9EB69983D7AQ36624649-ED2A7967-20EC-4C51-9481-3A574ECE7124Q36880400-8D5DA054-BE9B-49BD-B355-D212307F7C81Q37047803-026EB1C0-B8DF-48C8-B4F8-6E5C8C7D55D9Q37366944-DC4F5077-CA2C-4EB2-ADB1-FE02E2732AA9Q38798559-D22F8C5C-65CD-44E2-80A7-6612E94E0082Q41718616-7DA315DF-C257-41B2-94A3-D0A283D3BBE5Q44495670-71294E10-0723-475C-8F51-2446B8755BDAQ45068453-F05E4AF4-1FBA-4FC0-96E3-C4761D34FA96Q47907872-7C36D8DF-9D2F-45DE-9C29-232EB90CD3CBQ51153126-CB282F2C-568D-42C9-8EFB-393712F5A2E6Q51746593-A0728EA3-A249-4376-AAE8-1821FF44D979Q54314428-ACD19CC7-317E-45D1-9F37-25AC2B8AF7BEQ57999149-8F349FB4-8DFF-4904-84C3-EE3B8CE2B8DDQ58605208-C41DD408-8496-4BF8-8CCD-003466E5A106
P2860
Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Novel method for genomic analy ...... ant polycystic kidney disease.
@ast
Novel method for genomic analy ...... ant polycystic kidney disease.
@en
type
label
Novel method for genomic analy ...... ant polycystic kidney disease.
@ast
Novel method for genomic analy ...... ant polycystic kidney disease.
@en
prefLabel
Novel method for genomic analy ...... ant polycystic kidney disease.
@ast
Novel method for genomic analy ...... ant polycystic kidney disease.
@en
P2093
P356
P1433
P1476
Novel method for genomic analy ...... ant polycystic kidney disease.
@en
P2093
Daniel Levine
Debra G B Leonard
Hanna Rennert
Jon D Blumenfeld
Marina Balina
Raluca Anghel
Rimma Belenkaya
Stephanie Donahue
Thomas Parker
Ying-Cai Tan
P304
P356
10.1002/HUMU.20842
P577
2009-02-01T00:00:00Z